Haluk Topaloğlu

Active 1994–2025

100
Papers
18,554
Citations
75
h-index
99
i10-index

Citations

Citations per year for Haluk Topaloğlu1972: 1 citations1994: 1 citations1995: 10 citations1996: 27 citations1997: 34 citations1998: 32 citations1999: 32 citations2000: 34 citations2001: 47 citations2002: 85 citations2003: 112 citations2004: 89 citations2005: 88 citations2006: 110 citations2007: 71 citations2008: 97 citations2009: 127 citations2010: 74 citations2011: 111 citations2012: 92 citations2013: 124 citations2014: 131 citations2015: 143 citations2016: 128 citations2017: 124 citations2018: 175 citations2019: 583 citations2020: 694 citations2021: 658 citations2022: 478 citations2023: 348 citations2024: 675 citations2025: 203 citations2026: 8 citations1973–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,839 citing papers, 22.7% of this breakdownUnited Kingdom: 804 citing papers, 10% of this breakdownItaly: 596 citing papers, 7.4% of this breakdownGermany: 577 citing papers, 7.1% of this breakdownFrance: 414 citing papers, 5.1% of this breakdownCanada: 390 citing papers, 4.8% of this breakdownChina: 310 citing papers, 3.9% of this breakdownNetherlands: 310 citing papers, 3.8% of this breakdownAustralia: 261 citing papers, 3.2% of this breakdownJapan: 261 citing papers, 3.2% of this breakdownSpain: 250 citing papers, 3.1% of this breakdownBelgium: 186 citing papers, 2.3% of this breakdown
0%22.7%Other 23.4%

Fields

  • Biochemistry, Genetics and Molecular Biology49.4%
  • Medicine40%
  • Neuroscience6.9%
  • Nursing1.7%
  • Immunology and Microbiology0.8%
  • Agricultural and Biological Sciences0.3%
  • Other0.9%

Topics

  • Neurogenetic and Muscular Disorders Research9.2%
  • Muscle Physiology and Disorders8.8%
  • RNA modifications and cancer3.7%
  • Cardiomyopathy and Myosin Studies3.4%
  • RNA Research and Splicing2.7%
  • Mitochondrial Function and Pathology2.6%
  • Other69.6%

Coauthors

All papers

Open in search
  1. Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

    Authors: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 2,272

  2. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Saito Kayoko, Thomas W. Prior, Wendy K. Chung, Shou‐Mei Wu, Jacqueline Montes, Elena Mazzone, Marion Main, Caron Coleman, Richard Gee, Allan M. Glanzman, Anna‐Karin Kroksmark, Kristin J. Krosschell, Leslie Nelson, Kristy Rose, Agnieszka Stępień, Carole Vuillerot, Michael G. Vitale, Brian D. Snyder, Susana Quijano-Roy, Jean Dubousset, David M. Farrington, Jack Flynn, Matthew A. Halanski, Carol Hasler, Lotfi Miladi, Christopher Reilly, Benjamin D. Roye, Paul D. Sponseller, Muharrem Yazici, Rebecca Hurst, Enrico Bertini, Stacey Tarrant, Salesa Barja, Simona Bertoli, Thomas O. Crawford, Kevin D. Foust, Barbara Kyle, Lance H. Rodan, Helen Roper, Erin Seffrood, Kathryn J. Swoboda, Agnieszka Szlagatys‐Sidorkiewicz - Neuromuscular Disorders 2017 cited by 1,043

  3. Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuromuscular Disorders 2019 cited by 626

  4. The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard Roxburgh, Anna Łusakowska, Anna Kostera‐Pruszczyk, Janusz Zimowski, Rosário Santos, Elena Neagu, Svetlana Artemieva, Vedrana Milić Rašić, Dina Vojinović, Manuel Posada de la Paz, Clemens Bloetzer, P.Y. Jeannet, Franziska Joncourt, Jordi Díaz‐Manera, Eduard Gallardo, Ayşen Karaduman, Haluk Topaloğlu, Rasha El Sherif, Angela Stringer, Andriy Shatillo, Ann Martin, Holly L. Peay, M. Bellgard, Janbernd Kirschner, Kevin M. Flanigan, Volker Straub, Kate Bushby, Jan J.G.M. Verschuuren, Annemieke Aartsma‐Rus, Christophe Béroud, Hanns Lochmüller - Human Mutation 2015 cited by 744

  5. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

    Authors: , , , , , , , , , , , , , , , , , , , - European Journal of Neurology 2021 cited by 494

  6. Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of theNURTUREstudy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Muscle & Nerve 2023 cited by 107

  7. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pirjo Isohanni, Nelica Ivanović Radović, David Jacquier, Alusine Jalloh, Maria Jędrzejowska, Gwen Kandawasvika, Celestin Kaputu, Nfwama Kawatu, Kristin D. Kernohan, Janbernd Kirschner, Barbara Klink, Sherry Kodsy, Ange-Éric Kouame-Assouan, Ružica Kravljanac, Madara Kreile, Ivan Litvinenko, Hugh J. McMillan, Sandra Lucía Restrepo Mesa, Inaam Mohamed, Liljana Muaremoska Kanzoska, Yoram Nevo, Séraphin Nguefack, Kafula Lisa Nkole, Gina O’Grady, Declan O’Rourke, Maryam Oskoui, Flávia Piazzon, Dimitri Poddighe, Audronė Prasauskienė, Juan Carlos Prieto, Magnhild Rasmussen, Santara Razafindrasata, Narayan Chandra Saha, Kayoko Saito, Foksouna Sakadi, Modibo Sangaré, Mary Schroth, L. V. Shalkevich, Andriy Shatillo, Renu Suthar, Léna Szabó, Nana Nino Tatishvili, Mériem Tazir, Eduardo F. Tizzano, Haluk Topaloğlu, M. Tulinius, Ludo van der Pol, Gabriel Vázquez, Dimitry Vlodavets, Jithangi Wanigasinghe, Jo M. Wilmshurst, Hui Xiong, Dimitrios Zafeiriou, Eleni Zamba - Neuromuscular Disorders 2021 cited by 172

  8. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lindsay N. Alfano, Michelle Eagle, M. James, Linda Lowes, Anna Mayhew, Elena Mazzone, Leslie Nelson, Kristy Rose, Hoda Abdel‐Hamid, Susan Apkon, Richard J. Barohn, Enrico Bertini, Clemens Bloetzer, Lausanne Canton de Vaud, Russell J. Butterfield, B. Chabrol, Jong‐Hee Chae, Daehak-ro Jongno-gu, Giacomi Pietro Comi, Basil T. Darras, Jahannaz Dastgir, Isabelle Desguerre, Raúl G. Escobar, Erika Finanger, Michela Guglieri, Imelda Hughes, Susan T. Iannaccone, Kristi Jones, Peter Karachunski, Martin Kudr, Timothy Lotze, Jean K. Mah, Katherine D. Mathews, Yoram Nevo, Julie Parsons, Yann Péréon, Alexandra Prufer de Queiroz Campos Araújo, J. Ben Renfroe, Maria Bernadete Dutra de Resende, Monique M. Ryan, Kathryn Selby, Gihan Tennekoon, Giuseppe Vita - The Lancet 2017 cited by 455

  9. Use of Whole-Exome Sequencing to Determine the Genetic Basis of Multiple Mitochondrial Respiratory Chain Complex Deficiencies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2014 cited by 365

  10. Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy

    Authors: , , , , , , , , , , , , , , , , - Nature Genetics 2009 cited by 256

  11. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Farhad Bayat, Filippo Buccella, Alessandra Ferlini, En Kimura, J.C. van den Bergen, Miriam Rodrigues, Richard Roxburgh, Anna Łusakowska, Anna Kostera‐Pruszczyk, Rosário Santos, Elena Neagu, Svetlana Artemieva, Vedrana Milić Rašić, Dina Vojinović, Manuel Posada de la Paz, Clemens Bloetzer, Andrea Klein, Jordi Díaz‐Manera, Eduard Gallardo, Aynur Ayşe Karaduman, Tunca Oznur, Haluk Topaloğlu, Rasha El Sherif, Angela Stringer, Andriy Shatillo, Ann Martin, Holly L. Peay, Janbernd Kirschner, Kevin M. Flanigan, Volker Straub, Kate Bushby, Christophe Béroud, Jan J.G.M. Verschuuren, Hanns Lochmüller - Journal of Neuromuscular Diseases 2017 cited by 182

  12. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy

    Authors: , , , , , , , , , , , , - Nature Genetics 2000 cited by 413

  13. Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry

    Authors: , , , , , , , , , , , , , , - Science 2013 cited by 282

  14. Riboflavin-Responsive and -Non-responsive Mutations in FAD Synthase Cause Multiple Acyl-CoA Dehydrogenase and Combined Respiratory-Chain Deficiency

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Şafak Güçer, Annalisa Botta, Elena Pegoraro, Adriana Malena, Lodovica Vergani, Daniela Mazzà, Marcella Zollino, Daniele Ghezzi, Cécile Acquaviva, Tiina Tyni, Avihu Boneh, Thomas Meitinger, Tim M. Strom, Niels Gregersen, Johannes A. Mayr, Rita Horváth, Maria Barile, Holger Prokisch - The American Journal of Human Genetics 2016 cited by 149

  15. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome

    Authors: , , , , , , , , , , , , - Nature Genetics 2001 cited by 365

  16. Mutations in KLHL40 Are a Frequent Cause of Severe Autosomal-Recessive Nemaline Myopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cathy Kiraly‐Borri, Göknur Haliloğlu, Beril Talim, Diclehan Orhan, Gülsev Kale, Adrian Charles, Victoria A. Fabian, Mark R. Davis, Martin Lammens, Caroline A. Sewry, Adnan Manzur, Francesco Muntoni, Nigel F. Clarke, Kathryn N. North, Enrico Bertini, Yoram Nevo, E Willichowski, Inger Elisabeth Silberg, Haluk Topaloğlu, Alan H. Beggs, Richard J. N. Allcock, Ichizo Nishino, Carina Wallgren‐Pettersson, Naomichi Matsumoto, Nigel G. Laing - The American Journal of Human Genetics 2013 cited by 224

  17. Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion

    Authors: , , , , , , , , - European Journal of Human Genetics 2012 cited by 137

  18. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , - European Journal of Neurology 2023 cited by 194

  19. The clinical, histologic, and genotypic spectrum of SEPN1 -related myopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Norma B. Romero, Michel Fardeau, Carsten G. Bönnemann, B. Estournet, Pascale Richard, Susana Quijano‐Roy, Ulrike Schara, Ana Ferreiro - Neurology 2020 cited by 73

  20. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene

    Authors: , , , , , , , , , , , , , , , - Brain 2007 cited by 319

  21. Recessive TTN truncating mutations define novel forms of core myopathy with heart disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Human Molecular Genetics 2013 cited by 191

  22. Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2003 cited by 172

  23. A Congenital Muscular Dystrophy with Mitochondrial Structural Abnormalities Caused by Defective De Novo Phosphatidylcholine Biosynthesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2011 cited by 143

  24. Variants in the Oxidoreductase PYROXD1 Cause Early-Onset Myopathy with Internalized Nuclei and Myofibrillar Disorganization

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kristen J. Nowak, Beril Talim, Haluk Topaloğlu, Nigel G. Laing, Kathryn N. North, Daniel G. MacArthur, Sylvie Friant, Nigel F. Clarke, Robert J. Bryson‐Richardson, Carsten G. Bönnemann, Jocelyn Laporte, Sandra T. Cooper - The American Journal of Human Genetics 2016 cited by 106